01 Record
CVE-2023-43017
IBM Security Verify Access man in the middle
HighPUBLISHEDCNA: ibm
CNA base score8.2 CVSS v3.xCVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:H
02 Description
IBM Security Verify Access man in the middle
03 Exploitation and scoring
- Exploitation
- Assessed, none found. CISA's assessment recorded neither public exploit code nor evidence of exploitation when it was made.
- SSVC decision
- ExploitationnoneCISA recorded no public exploit code and no evidence of exploitation.
- AutomatablenoAt least one step from reconnaissance to exploitation cannot be reliably automated.
- Technical ImpacttotalSuccessful exploitation gives total control of the vulnerable component.
- EPSS probability
- 0.55% probability of exploitation activity in the next 30 days.
- EPSS percentile
- Equal to or higher than the score of 46.0% of scored records. A rank, not a probability.
- NVD base score
- 7.2 (CVSS v3.x), scored by the NVD independently of the CNA.
- NVD CVSS vector
- CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H
- NVD analysis status
- Modified. NVD last modified this record on 2026-06-17.
- Red Hat severity
- No Red Hat rating. Red Hat rates the CVEs that affect its products.
Exploit-prediction scores from FIRST. Independent scoring and analysis status from the NVD. Vendor severity from Red Hat. Exploitation assessment and catalog membership from CISA.
04 Metadata
- Published
- 2024-02-07 16:10Z2 YR AGO
- Last updated
- 2025-11-03 21:49Z11 MO AGO
- Reserved
- 2023-09-15
- Assigning CNA
- ibm
- Record state
- PUBLISHED
- Severity
- High (CVSS 8.2)
- CNA CVSS vector
- CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:H
- Weaknesses
- CWE-295Improper Certificate ValidationBase
- Data version
- 5.2
- Document digest
- 24026014213a6d10ee457c9c72815815e3285852396a29e6be25a92a235b83f1
05 Affected products
VendorProductVersionsPlatforms
06 References
- www.ibm.comhttps://www.ibm.com/support/pages/node/7106586
- exchange.xforce.ibmcloud.comhttps://exchange.xforce.ibmcloud.com/vulnerabilities/266155
- seclists.orghttp://seclists.org/fulldisclosure/2024/Nov/0